Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total revenues	$ 4,863	$ 4,822	$ 14,353	$ 14,346
Gross profit	2,026	1,935	5,930	5,766
Selling, general, and administrative	1,034	996	3,139	3,130
Research and development	316	322	967	890
Total operating expenses	1,350	1,318	4,106	4,020
Operating income	676	617	1,824	1,746
Interest and other financial charges – net	130	138	383	411
Non-operating benefit (income) costs	(102)	(94)	(306)	(332)
Other (income) expense – net	(9)	(63)	(1)	(85)
Income from continuing operations before income taxes	658	636	1,747	1,752
Benefit (provision) for income taxes	(168)	(250)	(435)	(550)
Net income from continuing operations	490	386	1,312	1,202
Income (loss) from discontinued operations, net of taxes	0	(4)	0	(4)
Net income	490	382	1,312	1,198
Net (income) loss attributable to noncontrolling interests	(19)	(7)	(40)	(33)
Net income attributable to GE HealthCare	470	375	1,272	1,165
Deemed preferred stock dividend of redeemable noncontrolling interest	0	0	0	(183)
Net income attributable to GE HealthCare common stockholders	$ 470	$ 375	$ 1,272	$ 982
Earnings per share from continuing operations attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	$ 1.03	$ 0.83	$ 2.79	$ 2.17
Diluted (in dollars per share)	1.02	0.83	2.77	2.16
Earnings per share attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	1.03	0.82	2.79	2.16
Diluted (in dollars per share)	$ 1.02	$ 0.82	$ 2.77	$ 2.15
Weighted-average number of shares outstanding:
Basic (in shares)	457	455	456	455
Diluted (in shares)	459	458	459	458
Product
Total revenues	$ 3,201	$ 3,186	$ 9,454	$ 9,530
Cost of revenue	2,033	2,076	6,045	6,197
Service
Total revenues	1,662	1,636	4,899	4,816
Cost of revenue	$ 805	$ 811	$ 2,378	$ 2,383